Search
Inspire Medical Systems Inc
INSPAdd to Watchlist
42.610USD
+1.480+3.60%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.23BMarket Cap
9.56P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Inspire Medical Systems Inc is 6.33, ranking 164 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 127.50, with a high of 180.00 and a low of 81.00.
Analyst Rating
Based on
18
analysts
Hold
Current Rating
68.800
Target Price
+61.46%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Inspire Medical Systems Inc
INSP
18
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Inspire Medical Systems Inc's expected revenue for the next quarter?
Inspire Medical Systems Inc's expected revenue is 198.46M.
What is Inspire Medical Systems Inc's price target?
Analysts forecast that Inspire Medical Systems Inc's price target is USD 127.50, with the highest forecast at USD 180.00 and the lowest forecast at USD 81.00.
How have Inspire Medical Systems IncINSP's recent earnings per share performed?
The market expectation was USD -0.39, while Inspire Medical Systems IncINSP's earnings per share (EPS) for the previous quarter was USD 4.70. EPS for the next quarter is expected at USD -0.07.
What is the analyst rating for Inspire Medical Systems Inc?
Based on the ratings of Inspire Medical Systems Inc's stock from 18 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
